 Armata Pharmaceuticals, Inc. NYSE American: ARMP Armata or the Company, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced results for the second quarter of 2020 and provided a corporate and clinical update. 